GlassScriptPhysician profile
Kinan Kassar
NPI 1902292907
$13,454.79
in general payments reported to CMS, 2019-2025
34 companies · $1,259 in 2025
The $1,259 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,607 · 2020: $747 · 2021: $1,754 · 2022: $2,402 · 2023: $3,597 · 2024: $2,089 · 2025: $1,259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,438 · Travel and Lodging: $2,507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,437.67 |
| Travel and Lodging | $2,507.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,599.80 | 2019-2025 | Optis, Xience Skypoint, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $2,371.05 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Boston Scientific Corporation | $2,057.34 | 2021-2025 | Watchman Flx, Watchman Access System, Emerge Push |
| Medtronic, INC. | $1,721.68 | 2021-2025 | Symplicity G3 |
| Amgen INC. | $617.80 | 2020-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $340.10 | 2019-2023 | Farxiga, Brilinta |
| Medtronic Vascular, INC. | $292.56 | 2020 | |
| Shockwave Medical, INC | $272.72 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $267.67 | 2021-2022 | |
| Chiesi USA, INC. | $178.09 | 2020-2025 | Kengreal |
| Inari Medical, INC. | $168.59 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $161.31 | 2023-2025 | Optowire, Cardiva Vascade 6/7f Vcs, Savvywire |
| Abiomed | $160.89 | 2024-2025 | Impella |
| E.R. Squibb & Sons, L.L.C. | $129.20 | 2024-2025 | Eliquis, Camzyos |
| Penumbra, INC. | $116.83 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $111.06 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.30 | 2023 | Lifevest |
| Novo Nordisk INC | $106.77 | 2019-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $93.91 | 2025 | |
| Biosense Webster, INC. | $59.30 | 2025 | Carto 3 |
| Stryker Corporation | $52.41 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Kestra Medical Technology Services, INC. | $49.94 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $46.57 | 2023-2024 | Heartrail, Glidewire |
| Esperion Therapeutics, INC. | $45.06 | 2023-2025 | Nexletol |
| Lexicon Pharmaceuticals, INC. | $40.10 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $35.77 | 2025 | Uptravi |
| Altathera Pharmaceuticals LLC | $29.41 | 2025 | Sotalol Hydrochloride |
| Atricure, INC. | $28.25 | 2023 | |
| Heartflow, INC. | $25.63 | 2024 | |
| Teleflex LLC | $18.44 | 2025 | Manta |
| Bayer Healthcare Pharmaceuticals INC. | $17.86 | 2025 | |
| Glaxosmithkline, LLC. | $14.61 | 2025 | Shingrix |
| American Regent | $8.94 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinan Kassar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.